Tolga Sutlu

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Veterinary virologyInnate immunityNanoelectronicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 31, 2023
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü

|Jul 19, 2022
Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination.

Fatma Betul Oktelik, Vuslat Yilmaz, Metin Yusuf Gelmez

|Feb 19, 2022
Human immunodeficiency virus type 1 impairs sumoylation.

Bilgül Mete, Emre Pekbilir, Bilge Nur Bilge

|May 05, 2019
Engineering antigen-specific NK cell lines against the melanoma-associated antigen tyrosinase via TCR gene transfer.

Ayhan Parlar, Ece Canan Sayitoglu, Didem Ozkazanc

|Jan 13, 2019
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells.

Michael Chrobok, Carin I M Dahlberg, Ece Canan Sayitoglu

Pageof 1